Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for SPG Blockade in Chronic Migraine
NCT04069897Phase 3Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Oct 2019
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in chronic migraine, sponsored by St. Olavs University Hospital. Started Oct 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT04069897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069897.